-+ 0.00%
-+ 0.00%
-+ 0.00%

According to Zhitong Finance App, Cansino Biotech (06185.HK) announced that the new drug marketing application (NDA) for adsorbed acell-free 100 (5 components) albinism vaccine (for people aged 6 and above) (Td5CP for adolescents and adults) developed by the company has recently obtained an acceptance notice from the China Drug Administration.

Zhitongcaijing·08/16/2026 10:17:00
Listen to the news
According to Zhitong Finance App, Cansino Biotech (06185.HK) announced that the new drug marketing application (NDA) for adsorbed acell-free 100 (5 components) albinism vaccine (for people aged 6 and above) (Td5CP for adolescents and adults) developed by the company has recently obtained an acceptance notice from the China Drug Administration.